Beyond safety: rethinking concomitant radiotherapy and trastuzumab deruxtecan in metastatic breast cancer - from feasibility to precision practice. [PDF]
BreastTan Y, Cheng B, He K, Xie X.
europepmc +1 more source
Efficacy and safety of local consolidative therapy combined with systemic therapy in driver-negative oligometastatic non-small cell lung cancer: a systematic review and meta-analysis. [PDF]
Front OncolHan H +6 more
europepmc +1 more source
Short-term clinical outcomes of cytoreductive radical prostatectomy combined with abiraterone-based androgen deprivation therapy in oligometastatic prostate cancer. [PDF]
Medicine (Baltimore)Li B +8 more
europepmc +1 more source
Efficacy comparison of first-line treatment regimens for stage IV esophageal squamous cell carcinoma with supraclavicular lymph node metastasis: A study of the oligometastatic subtype. [PDF]
Ther Adv Med OncolWang F +12 more
europepmc +1 more source
Preliminary exploration of the optimal timing of chemoimmunotherapy combined with radiotherapy for oligometastatic esophageal squamous cell carcinoma and analysis of prognostic factors: a multicenter retrospective study. [PDF]
Front OncolXu T +8 more
europepmc +1 more source
Emerging Genomic and Immunological Correlates Defining Oligometastatic Trajectories in Intermediate/High-Grade Soft-Tissue Sarcomas. [PDF]
Genes (Basel)Ottaiano A +6 more
europepmc +1 more source
Site-specific heterogeneity in treatment response among patients with metastatic bladder cancer: implications for oligometastatic disease-a retrospective cohort study. [PDF]
Transl Androl UrolWang T, Wei B.
europepmc +1 more source
European lung cancer congress 2026 - the thoracic radiation oncologist's view. [PDF]
Clin Transl Radiat OncolZehentmayr F +9 more
europepmc +1 more source